Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alcon Inc (NY: ALC )

85.57 +0.07 (+0.08%)
Official Closing Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 405,476
Open 85.38
Bid (Size) 83.47 (1)
Ask (Size) 89.69 (1)
Prev. Close 85.50
Today's Range 85.17 - 85.97
52wk Range 71.45 - 101.10
Shares Outstanding 489,219,355
Dividend Yield 0.31%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
From Alcon Inc. Investors
Via Business Wire
Earnings Scheduled For November 12, 2024
Via Benzinga

Performance

YTD
+11.07%
+11.07%
1 Month
-9.58%
-9.58%
3 Month
-10.24%
-10.24%
6 Month
-4.67%
-4.67%
1 Year
+17.48%
+17.48%

More News

Read More
Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
From Alcon Inc. Investors
Via Business Wire
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance
From Alcon Inc. Investors
Via Business Wire
Alcon Analysts Increase Their Forecasts After Q2 Results
Via Benzinga
Alcon Analysts Increase Their Forecasts Following Q1 Results
Via Benzinga
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value
Via MarketBeat
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
From Alcon Inc. Investors
Via Business Wire
S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Lowe's, Palo Alto Networks And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Week In Review: Eisai Enters $1.5 Billion Molecular Glues Pact With SEED
Via Talk Markets
US Stocks Trim Gains As Iran Mulls Attack On Israel; Gold, Oil Rally: What's Driving Markets Monday?
Via Benzinga
Nasdaq, S&P 500 Futures Climb After Volatile Week As Traders Eye Inflation Data and Retail Earnings: Strategist Says Not CPI But This Data Can Give People Lot Of Conviction
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Via Benzinga
Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
From Alcon Inc. Investors
Via Business Wire
ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Do You Have Your Eye On Vision Care Stocks?
Via Talk Markets
MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio?
Via Benzinga
Contact Lens Maker Alcon's Has New Growth Avenues, Analyst Upgrades Stock
Via Benzinga
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
2 Intriguing Medical Stocks To Buy For Steady Growth As Earnings Approach
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.